Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation
- PMID: 15848325
- DOI: 10.1016/j.ejcts.2004.12.031
Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation
Abstract
Objective: Ischemic mitral regurgitation can be treated with a restrictive mitral annuloplasty, with or without coronary revascularization. In this study, the extent of reverse remodeling of the left ventricle following this strategy is assessed, as well as the factors that influence it.
Methods: Eighty-seven consecutive patients with ischemic mitral regurgitation and a mean ejection fraction of 32+/-10% underwent restrictive mitral annuloplasty (downsizing by two ring sizes, median ring size 26), with additional coronary revascularization in 75 patients. All underwent transthoracic echocardiography 18 months after surgery to assess residual mitral regurgitation, mitral valve gradient and left ventricular end-systolic and end-diastolic dimensions. Univariate and multivariate analysis was performed to identify predictors for reverse remodeling, defined as a 10% reduction in left ventricular dimension. Receiver-operating characteristic analysis was used to identify cut-off values for preoperative left ventricular dimensions in predicting reverse remodeling.
Results: Early mortality was 8.0% (seven patients, three non-cardiac), late mortality was 7.5% (six patients, four non-cardiac). There were two reoperations (redo annuloplasty), and four readmissions for heart failure. At 29 months follow-up, NYHA class improved from 3.0+/-0.9 to 1.3+/-0.5 (P<0.01). Mitral regurgitation grade decreased from 3.1+/-0.5 to 0.6+/-0.6 at 18 months, left ventricular end-systolic dimension decreased from 52+/-8 to 44+/-11 mm (P<0.01), and end-diastolic dimension from 64+/-8 to 58+/-10mm (P<0.01). Multivariate analysis identified preoperative left ventricular end-diastolic dimension as the single best factor in predicting occurrence of reverse remodeling. For end-systolic dimension, 51mm was the optimal cut-off value to predict reverse remodeling (specificity and sensitivity 81%, area under curve 0.85); for end-diastolic dimension, the cut-off value was 65mm (specificity and sensitivity 89%, area under curve 0.92).
Conclusions: Stringent restrictive mitral annuloplasty with or without revascularization provides excellent clinical results with acceptable mortality. At 18 months follow-up, there is no significant residual mitral regurgitation. Reverse remodeling occurs in the majority of patients, but is limited by preoperative left ventricular dimensions. In patients with a left ventricular end-diastolic dimension exceeding 65mm, additional surgical procedures are necessary to try and obtain reverse remodeling in this subgroup.
Similar articles
-
Baseline left ventricular function and surgical annular stiffening to predict outcome and reverse left ventricular remodeling after undersized annuloplasty for intermediate-degree ischemic mitral regurgitation.J Thorac Cardiovasc Surg. 2010 Jun;139(6):1529-38. doi: 10.1016/j.jtcvs.2009.08.043. Epub 2009 Dec 6. J Thorac Cardiovasc Surg. 2010. PMID: 19969313
-
Restrictive mitral valve annuloplasty for chronic ischemic mitral regurgitation: a 5-year clinical experience with the physio ring.Heart Surg Forum. 2008;11(4):E225-30. doi: 10.1532/HSF98.20081028. Heart Surg Forum. 2008. PMID: 18782701
-
Early and late results of restrictive mitral valve annuloplasty in 121 patients with cardiomyopathy and chronic mitral regurgitation.Thorac Cardiovasc Surg. 2008 Aug;56(5):262-8. doi: 10.1055/s-2008-1038420. Thorac Cardiovasc Surg. 2008. PMID: 18615371
-
Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients.J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):109-14. doi: 10.2459/JCM.0b013e32831c84b0. J Cardiovasc Med (Hagerstown). 2009. PMID: 19377377 Review.
-
Mitral reconstruction in cardiomyopathy.J Heart Valve Dis. 2002 Jan;11 Suppl 1:S26-31. J Heart Valve Dis. 2002. PMID: 11843517 Review.
Cited by
-
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.Eur Heart J. 2017 Mar 1;38(9):648-660. doi: 10.1093/eurheartj/ehw543. Eur Heart J. 2017. PMID: 28025189 Free PMC article. Clinical Trial.
-
Imaging of Valvular Heart Disease in Heart Failure.Card Fail Rev. 2018 Aug;4(2):78-86. doi: 10.15420/cfr.2018.16.1. Card Fail Rev. 2018. PMID: 30206481 Free PMC article. Review.
-
Long-term echocardiographic follow-up after posterior mitral annuloplasty using a vascular strip for ischemic mitral regurgitation: ten-years of experience at a single center.J Korean Med Sci. 2011 Dec;26(12):1582-90. doi: 10.3346/jkms.2011.26.12.1582. Epub 2011 Nov 29. J Korean Med Sci. 2011. PMID: 22147995 Free PMC article.
-
Mitral valve repair in the treatment of mitral regurgitation.Curr Treat Options Cardiovasc Med. 2009 Dec;11(6):419-25. doi: 10.1007/s11936-009-0044-2. Curr Treat Options Cardiovasc Med. 2009. PMID: 19930979
-
Genes causing inherited forms of cardiomyopathies. A current compendium.Herz. 2009 Mar;34(2):98-109. doi: 10.1007/s00059-009-3215-8. Herz. 2009. PMID: 19370325 Review.
MeSH terms
LinkOut - more resources
Full Text Sources